Envisagenics

Series-B+
envisagenics.com Biotech & Healthcare New York, United States
Total Funding $45M
Latest Round $25M Series-B+
Last Announced Jun 5, 2024
Investors 8 Backers
Decision Makers 6 Verified

About Envisagenics

RNA Therapeutics Development

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters New York, United States
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website envisagenics.com
Domain Registered Date Mar 28, 2013

Social & Network Presence

X / Twitter Profile @envisagenics (1.1K followers) Created on Dec 2013
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $25,000,000 · Series-B+

    startupintros.com

  2. Capital Raise

    Raised $19,000,000 · Series-A

    startupintros.com

  3. Capital Raise

    Raised $1,000,000 · Seed

    startupintros.com

  4. Milestone

    X account created (@envisagenics)

    1.1K followers

  5. Milestone

    Website domain registered

    envisagenics.com

Investors & Backers

8
Bristol-Myers Squibb
Empire State Development
M12
Madrona
National Cancer Institute
New York Ventures
Red Cell Partners
Third Kind Venture Capital

Funding History

3 Rounds
Series-B+ · Jun 5, 2024
Series-A · Sep 1, 2021
Seed · Apr 1, 2018

Founders & Leadership

3

Maria Pineda

CEO & Co-founder

Work email & phone locked Unlock →

Martin Akerman

CTO & Co-founder

Work email & phone locked Unlock →

Sudhir Rao

Chief Business Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts